# FDA Inspection 984729 - McKesson Corporation dba RxPak - July 27, 2016

Source: https://www.keypedia.com/records/fda_inspections/mckesson-corporation-dba-rxpak/ff09fd5a-8906-41b6-a175-95f00bbd6460
Source feed: FDA_Inspections

> FDA Inspection 984729 for McKesson Corporation dba RxPak on July 27, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 984729
- Company Name: McKesson Corporation dba RxPak
- Inspection Date: 2016-07-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1046405 - 2018-03-22](https://www.keypedia.com/records/fda_inspections/mckesson-corporation-dba-rxpak/95128efc-57ed-4764-b2ee-a98c44065eae)
- [FDA Inspection 650331 - 2010-03-01](https://www.keypedia.com/records/fda_inspections/mckesson-corporation-dba-rxpak/0e09a648-088a-4e9e-a4e9-0e6dc10899b7)

Company: https://www.keypedia.com/companies/mckesson-corporation-dba-rxpak/d65f7265-a6b2-409b-958a-a69365e81ded

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c